Ph-like ALL Gene Fusion and Mutation Detection with Interpretation
Label Mnemonic: | HEMEALL |
Epic code: | LAB8912 |
Order form: | Comprehensive Hematopathology Requisition |
Supply order: | Supply Order Form |
Billing: | Billing Policies |
CPT code: | 81450 |
Specimen(s):
Blood, Bone Marrow Aspirate, Tissue
Collection Medium:
![]() |
Pink top tube 6 mL (K2-EDTA) |
Minimum:
Whole blood (EDTA anti-coagulated; 6 mL pink top tube) or bone marrow aspirate (EDTA anti-coagulated; pink or lavender top tube) or tissue formalin fixed and paraffin embedded.
Rejection Criteria:
Tumor specimens containing less than 20% tumor cells may be unacceptable.
Testing Schedule:
Testing is batched.
Turn Around Time:
7-10 days upon receipt in laboratory
Methodology:
Reverse transcription, anchored multiplexed PCR for targeted next-generation sequencing is performed on RNA isolated from bone marrow, blood or formalin-fixed paraffin embedded tissue.
Instructions:
Testing requires dedicated collection tube.
Sample Processing:
Do Not Centrifuge.
Sample Storage:
Refrigerate.
Transport Instructions:
Place specimen into zip-lock type bag, seal bag.
Recommend early AM overnight shipping or equivalent if not on courier service.
Ship refrigerated.
Place requisition into outside pocket of bag.
Protect phlebotomy tube from excessive heat and ship in cooled container during summer months.
Recommend early AM overnight shipping or equivalent if not on courier service.
Ship refrigerated.
Place requisition into outside pocket of bag.
Protect phlebotomy tube from excessive heat and ship in cooled container during summer months.
This assay is used to detect these alternative RNA fusions and variants in the following genes: common variants in BRAF, IKZF1, IL7R, JAK1, JAK3, KRAS, NRAS, and SH2B3, and fusion transcripts involving rearrangements of ABL1, ABL2, BLNK3, CBL3, CRLF2, CSF1R, DGKH3, EPOR, FGFR1, FLT3, IKZF1, IL2RB, JAK2, LYN3, NTRK3, PDGFRA, PDGFRB, PTK2B, TSLP, and TYK2.
Results Reported: Fusion or variants detected.